Physician profile
Gary E Silverman
NPI 1790767762
$3,550.54
in general payments reported to CMS, 2019-2025
19 companies · $709 in 2025
The $709 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $218 · 2021: $313 · 2022: $468 · 2023: $439 · 2024: $1,117 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,265.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $866.75 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Mylux Patient Kit With Mobile Device, Accolade Sr |
| Janssen Pharmaceuticals, INC | $479.48 | 2019-2024 | Xarelto |
| Abbott Laboratories | $455.73 | 2019-2025 | Perclose Prostyle, Diamondback Coronary |
| Medtronic, INC. | $437.17 | 2024-2025 | Micra, Symplicity G3, Corevalve Evolut R |
| Abiomed | $278.36 | 2020-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $214.44 | 2024-2025 | |
| Karl Storz Endoscopy-America | $147.73 | 2023 | |
| Edwards Lifesciences Corporation | $130.17 | 2024 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.50 | 2025 | Lifevest |
| Shockwave Medical, INC | $106.72 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $71.65 | 2019-2024 | Farxiga |
| Penumbra, INC. | $56.20 | 2021-2024 | Indigo System |
| Cardiovascular Systems INC. | $53.79 | 2020-2023 | Diamondback Coronary |
| Kiniksa Pharmaceuticals International, Plc | $35.17 | 2024 | Arcalyst |
| Amgen INC. | $25.11 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $19.58 | 2020 | |
| Acist Medical Systems, INC. | $19.42 | 2024 | |
| Cagent Vascular INC | $18.38 | 2024 | Serrantor |
| Biotronik INC. | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Silverman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.